FdaApplication
NDA 021861
Identifiers
- fda_app_no: NDA021861
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2008-04-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PATANASE | OLOPATADINE HYDROCHLORIDE | 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED;NASAL |
1 product